Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival (Q33831838)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival |
scientific article |
Statements
Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival (English)
Takayoshi Kiba
Takuo Ito
Yoshiko Okikawa
Miki Kido
Akiko Kimura
Keita Kameda
Fumiaki Miyamae
Suzuko Tanaka
Misao Atsumi
Yoko Sumitani
Yoshimi Shitakubo
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference